• Return to Headlines

Celgene Corp: 52-Week High Recently Eclipsed (CELG)

By James Quinn

Shares of Celgene Corp (NASDAQ:CELG) traded at a new 52-week high today of $99.08. So far today approximately 64,000 shares have been exchanged, as compared to an average 30-day volume of 3.4 million shares.

Potential upside of 14.2% exists for Celgene Corp, based on a current level of $99.04 and analysts' average consensus price target of $113.09. Celgene Corp shares have support at the 50-day moving average (MA) of $93.77 and additional support at the 200-day MA of $88.57.

Celgene Corporation, a biopharmaceutical company, discovers, develops, and commercializes therapies for the treatment of cancer and inflammatory diseases worldwide.

Celgene Corp share prices have moved between a 52-week high of $99.08 and a 52-week low of $58.59 and are now trading 69% above that low price at $99.04 per share. In the last five trading sessions, the 50-day moving average (MA) has climbed 0.2% while the 200-day MA has risen 0.6%.

SmarTrend is tracking the current trend status for Celgene Corp and will alert subscribers who have CELG in their portfolio or watchlist when shares have changed trend direction.

Keywords: 52 week high/lows celgene corp

Ticker(s): CELG